Boson has participated in the AACC exhibition in the USA from 26-28 July 2022, which ended successfully yesterday.
![](https://bosoncovt.com/wp-content/uploads/2024/05/AACC-Boson-Booth-1024x691.jpg)
At the exhibition, Boson Biotech exhibited rapid test reagents including COVID-19 test, infectious disease test and FOB test, etc., which were warmly welcomed by the attending customers. One of the most popular products is the FDA EUA Authorized Rapid SARS-CoV-2 Antigen Test Card for home use, the customers showed a high level of interest in the product.
![](https://bosoncovt.com/wp-content/uploads/2024/05/AACC-COVID-19-Test-Sample-1024x768.jpg)
The exhibition also heralds the further expansion of Boson Biotech into the North American market. After obtaining FDA EUA Authorization and Health Canada Emergency Authorization for COVID-19 products, Boson Biotech will also expand the registration of other products in the North American market, as well as the registration of COVID-19 products in other markets.